News coverage about Mesoblast (NASDAQ:MESO) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Mesoblast earned a media sentiment score of 0.23 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.258265871915 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

These are some of the media stories that may have effected Accern Sentiment’s scoring:

A number of analysts recently issued reports on the company. Cantor Fitzgerald reiterated a “buy” rating on shares of Mesoblast in a research note on Wednesday, August 23rd. Maxim Group set a $14.00 price objective on Mesoblast and gave the company a “buy” rating in a research note on Wednesday, August 30th. CIBC assumed coverage on Mesoblast in a research note on Thursday, August 31st. They set an “outperform” rating and a $16.00 price objective on the stock. Oppenheimer assumed coverage on Mesoblast in a research note on Thursday, August 31st. They set an “outperform” rating and a $16.00 price objective on the stock. Finally, Zacks Investment Research upgraded Mesoblast from a “hold” rating to a “buy” rating and set a $6.50 price objective on the stock in a research note on Wednesday, October 4th. Three analysts have rated the stock with a sell rating, two have assigned a hold rating and four have given a buy rating to the company’s stock. Mesoblast presently has an average rating of “Hold” and a consensus target price of $13.14.

Shares of Mesoblast (MESO) opened at $6.32 on Tuesday. Mesoblast has a one year low of $4.80 and a one year high of $12.50.

ILLEGAL ACTIVITY WARNING: “Mesoblast (MESO) Receiving Somewhat Favorable News Coverage, Study Shows” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://www.watchlistnews.com/mesoblast-meso-receiving-somewhat-favorable-news-coverage-study-shows/1772164.html.

Mesoblast Company Profile

Insider Buying and Selling by Quarter for Mesoblast (NASDAQ:MESO)

Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter.